These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6230234

  • 21. Multifocal osteogenic sarcoma in the seventh decade.
    Vento JA, Edkin R, Slavin JD, Spencer RP.
    Clin Nucl Med; 1986 Apr; 11(4):282-3. PubMed ID: 3456863
    [Abstract] [Full Text] [Related]

  • 22. Metastasis of humeral osteosarcoma to the contralateral breast detected by 99mTc-MDP skeletal scintigraphy.
    Basu S, Moghe SH, Shet T.
    Jpn J Radiol; 2009 Dec; 27(10):455-7. PubMed ID: 20035419
    [Abstract] [Full Text] [Related]

  • 23. "Cold spot" on bone scan at the site of primary osteosarcoma.
    Siddiqui AR, Ellis JH.
    Eur J Nucl Med; 1982 Dec; 7(10):480-1. PubMed ID: 6216109
    [Abstract] [Full Text] [Related]

  • 24. Unusual site of extraosseous uptake of Tc 99m-HMDP due to subcutaneous heparin injections. Report of two cases.
    Amico S, Lucas P, Liehn JC, Valeyre J.
    Eur J Nucl Med; 1989 Dec; 15(10):670-2. PubMed ID: 2806330
    [Abstract] [Full Text] [Related]

  • 25. Pulmonary tumor-embolism from intravascular osteosarcoma demonstrated by bone scintigraphy.
    Hoefnagel CA, Marcuse HR, Somers R.
    Clin Nucl Med; 1982 Dec; 7(12):574-6. PubMed ID: 6217015
    [No Abstract] [Full Text] [Related]

  • 26. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S, Ishimaru T, Maeda H, Sakata T, Yamasaki K, Akagi H.
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract] [Full Text] [Related]

  • 27. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
    Schuemichen C, Krause T, Umbach G, Wolff T.
    Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
    [Abstract] [Full Text] [Related]

  • 28. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma.
    Zissimopoulos A, Zanglis A, Andreopoulos D, Baziotis N.
    Hell J Nucl Med; 2005 Feb; 8(3):162-4. PubMed ID: 16390022
    [Abstract] [Full Text] [Related]

  • 29. Spectrum of technetium-99m methylene diphosphonate (99mTc MDP) uptake in Osteosarcoma.
    Gill SM, Mufty S, Hassan A.
    J Pak Med Assoc; 2023 Jul; 73(7):1551-1552. PubMed ID: 37469083
    [Abstract] [Full Text] [Related]

  • 30. Tc-99m MDP uptake in soft tissue extraskeletal metastasis from osteogenic sarcoma.
    Pace WM, Ross McDougall I.
    Clin Nucl Med; 2000 May; 25(5):333-4. PubMed ID: 10795688
    [Abstract] [Full Text] [Related]

  • 31. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma.
    Cermik TF, Salan A, Firat MF, Berkarda S.
    Clin Nucl Med; 2003 Jul; 28(7):599-600. PubMed ID: 12819421
    [No Abstract] [Full Text] [Related]

  • 32. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients.
    McKillop JH, Etcubanas E, Goris ML.
    Cancer; 1981 Sep 01; 48(5):1133-8. PubMed ID: 6268278
    [Abstract] [Full Text] [Related]

  • 33. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging.
    Sommer HJ, Knop J, Heise U, Winkler K, Delling G.
    Cancer; 1987 Jan 15; 59(2):252-8. PubMed ID: 3467818
    [Abstract] [Full Text] [Related]

  • 34. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
    Nakano S, Hasegawa Y, Shiomura K, Ibuka K, Hashizume T.
    Kaku Igaku; 1981 Dec 15; 18(10):1485-8. PubMed ID: 6210789
    [No Abstract] [Full Text] [Related]

  • 35. Detection of adrenal metastasis from osteosarcoma by Tc-99m MDP scintigraphy.
    Kauffman WM, Winer-Muram H, Sandlund JT.
    Clin Nucl Med; 1995 Aug 15; 20(8):741. PubMed ID: 7586888
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
    Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K.
    Kaku Igaku; 1981 Nov 15; 18(9):1315-9. PubMed ID: 6461790
    [No Abstract] [Full Text] [Related]

  • 37. Primary osteogenic sarcoma of the breast demonstrated by Tc-99m MDP scintigraphy.
    Lee JK, Sun SS.
    Clin Nucl Med; 1998 Sep 15; 23(9):619. PubMed ID: 9735989
    [No Abstract] [Full Text] [Related]

  • 38. Uptake of 99Tcm-MDP in lung metastasis from osteosarcoma: clinical and animal studies.
    Tsuji T, Yamamuro T, Kotoura Y, Matsumoto M, Tanaka H, Tanaka C, Toguchida J, Endo K, Sakahara H, Koizumi M.
    Nucl Med Commun; 1988 Dec 15; 9(12):947-54. PubMed ID: 3217065
    [Abstract] [Full Text] [Related]

  • 39. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G, McAfee JG, Thomas FD, Feld TA, Zapf-Longo C, Palladino E.
    Radiology; 1983 Dec 15; 149(3):823-8. PubMed ID: 6316414
    [Abstract] [Full Text] [Related]

  • 40. [Scintigraphy with 99mTc-methylene diphosphonate for the detection and localization of rhabdomyolysis].
    Schicha H, Rumpf KW, Kaiser H, Emrich D.
    Nuklearmedizin; 1984 Dec 15; 23(6):287-91. PubMed ID: 6241670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.